These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30717947)

  • 21. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome.
    Lima BL; França AV; Pazin-Filho A; Araújo WM; Martinez JA; Maciel BC; Simões MV; Terra-Filho J; Martinelli AL
    Mayo Clin Proc; 2004 Jan; 79(1):42-8. PubMed ID: 14708947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.
    Shalimar ; Gamanagatti SR; Patel AH; Kedia S; Nayak B; Gunjan D; Ranjan G; Paul SB; Acharya SK
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1174-1182. PubMed ID: 28763339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital.
    Hamid RS; Tanveer-ul-haq ; Azeemuddin M; Sajjad Z; Chishti I; Salam B
    J Pak Med Assoc; 2011 Apr; 61(4):336-9. PubMed ID: 21465967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt.
    Nistal MW; Pace A; Klose H; Benten D; Lohse AW
    Thorax; 2013 Sep; 68(9):889-90. PubMed ID: 22382598
    [No Abstract]   [Full Text] [Related]  

  • 25. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
    Gandini R; Konda D; Simonetti G
    Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation.
    Grilo I; Pascasio JM; Tirado JL; López-Pardo FJ; Ortega-Ruiz F; Sousa JM; Rodríguez-Puras MJ; Ferrer MT; Gómez-Bravo MÁ; Grilo Reina A
    Rev Esp Enferm Dig; 2017 May; 109(5):335-343. PubMed ID: 28301945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression.
    De BK; Sen S; Biswas PK; Mandal SK; Das D; Das U; Guru S; Bandyopadhyay K
    Gastroenterology; 2002 Apr; 122(4):897-903. PubMed ID: 11910341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic venousaplasty and transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with occlusion of the hepatic veins].
    Wu XJ; Cao JM; Han JM; Li JS
    Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):131-4. PubMed ID: 23711005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatopulmonary syndrome.
    Koch DG; Fallon MB
    Clin Liver Dis; 2014 May; 18(2):407-20. PubMed ID: 24679503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatopulmonary syndrome: What we know and what we would like to know.
    Grilo-Bensusan I; Pascasio-Acevedo JM
    World J Gastroenterol; 2016 Jul; 22(25):5728-41. PubMed ID: 27433086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.
    Jahangiri Y; Pathak P; Tomozawa Y; Li L; Schlansky BL; Farsad K
    J Vasc Interv Radiol; 2019 Jun; 30(6):866-872.e4. PubMed ID: 31053265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center.
    Fitsiori K; Tsitskari M; Kelekis A; Filippiadis D; Triantafyllou K; Brountzos E
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):691-7. PubMed ID: 23860938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse oximetry is insufficient for timely diagnosis of hepatopulmonary syndrome in children with liver cirrhosis.
    Hoerning A; Raub S; Neudorf U; Müntjes C; Kathemann S; Lainka E; Stehling F; Hoyer PF; Gerner P
    J Pediatr; 2014 Mar; 164(3):546-52.e1-2. PubMed ID: 24321540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
    Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome.
    Hayek G; Ronot M; Plessier A; Sibert A; Abdel-Rehim M; Zappa M; Rautou PE; Valla D; Vilgrain V
    Radiology; 2017 Apr; 283(1):280-292. PubMed ID: 27797679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results.
    Saad WE; Saad NE; Davies MG; Bozorgdadeh A; Orloff MS; Patel NC; Abt PL; Lee DE; Sahler LG; Kitanosono T; Sasson T; Waldman DL
    J Vasc Interv Radiol; 2006 Jun; 17(6):995-1002. PubMed ID: 16778233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.
    Rössle M; Olschewski M; Siegerstetter V; Berger E; Kurz K; Grandt D
    Surgery; 2004 Apr; 135(4):394-403. PubMed ID: 15041963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study.
    Wong RJ; Ge J; Boike J; German M; Morelli G; Spengler E; Said A; Desai A; Couri T; Paul S; Frenette C; Verna EC; Goel A; Fallon M; Thornburg B; VanWagner L; Lai JC; Kolli KP
    J Vasc Interv Radiol; 2023 Aug; 34(8):1364-1371. PubMed ID: 37100199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.